The Gut as the Motor of MOF: Managing the Critically Ill Surgical Gut

Dr Neeraj Manikath , claude.ai

Abstract

The gastrointestinal tract plays a pivotal role in the pathogenesis of multiple organ failure (MOF) in critically ill surgical patients. The "gut hypothesis" of MOF posits that splanchnic hypoperfusion, mucosal barrier dysfunction, and bacterial translocation initiate a cascade of systemic inflammation. This review examines five critical aspects of surgical gut management in the intensive care unit: intra-abdominal hypertension and abdominal compartment syndrome, acute colonic pseudo-obstruction, enterocutaneous fistula management, post-pyloric feeding strategies, and open abdomen care following damage control surgery. Understanding these concepts is essential for postgraduate critical care physicians managing complex surgical patients.

Introduction

The gut serves as both victim and perpetrator in critical illness. Splanchnic hypoperfusion during shock states leads to mucosal ischemia, breakdown of the gut barrier, and subsequent bacterial translocation—processes that fuel systemic inflammatory response syndrome (SIRS) and progress toward MOF[1]. In surgical patients, the challenges multiply: operative trauma, anastomotic complications, peritonitis, and alterations in intra-abdominal pressure create a perfect storm for gut dysfunction. This article provides evidence-based guidance with practical clinical pearls for managing the critically ill surgical gut.

Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS): Measurement and Staging

Definitions and Pathophysiology

Intra-abdominal hypertension (IAH) is defined as sustained intra-abdominal pressure (IAP) ≥12 mmHg, while abdominal compartment syndrome (ACS) represents sustained IAP >20 mmHg with new organ dysfunction[2]. The World Society of the Abdominal Compartment Syndrome (WSACS) has standardized these definitions, revolutionizing recognition and management.

IAH occurs in 30-50% of mechanically ventilated ICU patients and progresses to ACS in 5-10%[3]. The pathophysiology involves a vicious cycle: increased IAP compresses the inferior vena cava, reducing venous return and cardiac output. Simultaneously, elevated intra-thoracic pressure from diaphragmatic elevation reduces pulmonary compliance. Renal perfusion pressure (mean arterial pressure minus IAP) falls, causing acute kidney injury. Splanchnic hypoperfusion exacerbates gut ischemia, perpetuating the inflammatory cascade.

Measurement Techniques

Gold Standard: Intravesicular Pressure Measurement

The bladder serves as a passive pressure transducer. The standardized technique involves:

Ensure supine position at end-expiration
Zero the transducer at the iliac crest (mid-axillary line)
Instill 25 mL sterile saline into empty bladder via Foley catheter
Clamp drainage tubing distally
Measure pressure after 30-60 seconds of equilibration[4]

Pearl: Use minimal instillation volumes (25 mL maximum). Larger volumes artificially elevate readings, particularly in patients with reduced bladder compliance from prior surgery or radiation.

Oyster: Never measure IAP during active abdominal muscle contraction (coughing, ventilator dyssynchrony). Use adequate sedation and ensure neuromuscular blockade has worn off if recently administered.

Hack: For continuous monitoring in high-risk patients, dedicated IAP monitoring catheters (e.g., AbViser) provide trend data without repeated manual measurements, allowing earlier intervention.

Grading System

The WSACS classification stratifies IAH severity:

Grade I: IAP 12-15 mmHg
Grade II: IAP 16-20 mmHg
Grade III: IAP 21-25 mmHg
Grade IV: IAP >25 mmHg

ACS is further classified as:

Primary: Arises from abdomino-pelvic pathology (trauma, peritonitis, hemorrhage)
Secondary: Originates from extra-abdominal sources (massive resuscitation, capillary leak, sepsis)
Tertiary (Recurrent): Redevelopment after initial treatment

Management Strategy

Medical Management (IAP 12-20 mmHg):

Improve abdominal wall compliance: Sedation, analgesia, neuromuscular blockade if necessary
Evacuate intraluminal contents: Nasogastric decompression, rectal tube, prokinetics (metoclopramide 10 mg IV q6h, erythromycin 200 mg IV q6h)
Drain intra-abdominal fluid: Percutaneous drainage of ascites or collections
Optimize fluid balance: Avoid excessive crystalloid resuscitation; use diuretics or renal replacement therapy for fluid removal
Organ support: Maintain abdominal perfusion pressure (APP = MAP - IAP) >60 mmHg using vasopressors[5]

Pearl: The APP is a better resuscitation endpoint than MAP alone in IAH patients. Target APP >60 mmHg correlates with improved outcomes.

Surgical Decompression (ACS with IAP >20 mmHg plus organ failure):

Decompressive laparotomy remains definitive treatment. The threshold for intervention balances the morbidity of laparostomy against the mortality of untreated ACS (approaching 100%)[6].

Hack: In borderline cases (IAP 18-22 mmHg), calculate the difference between peak inspiratory pressure (PIP) and IAP. When PIP-IAP <10 cmH₂O, pulmonary mechanics are severely compromised, favoring surgical decompression even if other organ dysfunction is subtle.

Oyster: Post-decompression reperfusion syndrome causes transient hypotension, hyperkalemia, metabolic acidosis, and myocardial stunning. Prepare with volume loading, ionotropic support, and close electrolyte monitoring. Consider prophylactic calcium chloride (500-1000 mg IV) immediately upon fascial opening.

Post-Operative Ileus vs. Ogilvie's Syndrome: Differentiating and Managing Colonic Pseudo-Obstruction

Clinical Differentiation

Post-operative ileus (POI) represents transient intestinal hypomotility affecting the entire gastrointestinal tract, typically resolving within 3-5 days. Acute colonic pseudo-obstruction (ACPO, Ogilvie's syndrome) involves massive colonic dilatation without mechanical obstruction, predominantly affecting the proximal colon[7].

Key Differentiating Features:

Feature	POI	Ogilvie's Syndrome
Timing	Immediate post-op	Days 3-7 post-op or with acute illness
Location	Entire GI tract	Predominantly colon
Abdominal exam	Mild distension, reduced sounds	Marked distension, tympany
Cecal diameter	Usually <9 cm	Often >10 cm
Clinical course	Self-limited	Progressive risk of perforation

Pearl: Ogilvie's syndrome classically follows orthopedic or cardiac surgery, sepsis, or occurs with electrolyte abnormalities (hypokalemia, hypomagnesemia, hypophosphatemia) and medications (opioids, anticholinergics, calcium channel blockers).

Diagnostic Approach

Imaging: Abdominal radiography shows colonic dilatation; CT scan excludes mechanical obstruction and identifies the transition point (absent in pseudo-obstruction). Water-soluble contrast enema can confirm absence of distal obstruction.

Critical threshold: Cecal diameter >12 cm carries 23% perforation risk; >14 cm increases risk to 50%[8]. Measure at the widest point on supine radiography.

Oyster: Don't rely solely on clinical assessment. Abdominal distension may be masked in obese patients or those with rigid abdominal walls from prior surgery. Serial imaging is mandatory.

Management Protocol

Conservative Management (Cecal diameter <12 cm):

Discontinue offending agents: Reduce opioids, stop anticholinergics
Correct metabolic derangements: Target K⁺ >4.0 mEq/L, Mg²⁺ >2.0 mg/dL, PO₄³⁻ >3.0 mg/dL
Nasogastric decompression: Reduces proximal gas
Early mobilization: Ambulation when feasible
Rectal tube: Provides distal decompression
Avoid neostigmine initially in post-operative patients due to anastomotic concerns

Pharmacologic Intervention (12-14 cm or failed conservative treatment):

Neostigmine (acetylcholinesterase inhibitor) is first-line pharmacotherapy:

Dose: 2-2.5 mg IV over 3-5 minutes
Monitor on telemetry with atropine at bedside (bradycardia risk)
Response rate: 60-90% with clinical decompression within 30 minutes[9]
May repeat once after 24 hours if incomplete response
Contraindications: Bradycardia, bronchospasm, recent anastomosis (<7 days), peritonitis

Hack: Pre-treat with glycopyrrolate 0.2 mg IV (cardiac-selective antimuscarinic) to minimize bradycardia while preserving neostigmine's prokinetic effect on the gut. This reduces abrupt hemodynamic changes.

Pearl: Response to neostigmine is dramatic—patients often pass large volumes of flatus/stool within minutes. Ensure adequate perineal care supplies are ready!

Endoscopic Decompression (Failed neostigmine or cecal diameter >14 cm):

Colonoscopy with placement of decompression tube achieves immediate success in 70-90% but carries perforation risk (1-3%)[10]. Performed by experienced endoscopists only.

Surgical Intervention:

Reserved for perforation, ischemia, or failed medical/endoscopic therapy. Options include cecostomy (tube or surgical) or, rarely, resection for ischemic segments.

Enterocutaneous Fistulas and High-Output Stomas: A Primer on Fluid and Electrolyte Management

Pathophysiology and Classification

Enterocutaneous fistulas (ECF) arise in 0.8-2% of abdominal surgeries but complicate 15-25% of reoperations for intra-abdominal sepsis[11]. The mortality remains 5-20%, predominantly from sepsis and malnutrition.

Classification by output:

Low output: <200 mL/24h (85% spontaneous closure)
Moderate output: 200-500 mL/24h (50% closure)
High output: >500 mL/24h (25% closure, highest metabolic challenge)[12]

Anatomic classification: Proximal fistulas (jejunum) produce higher volumes with greater electrolyte losses than distal fistulas (ileum/colon).

Metabolic Consequences

High-output fistulas/stomas cause:

Hypovolemia: Fluid losses of 2-6 L/day
Hyponatremia: Na⁺ concentration in jejunal fluid: 100-140 mEq/L
Hypokalemia: K⁺ losses: 5-15 mEq/L of effluent
Hypomagnesemia: Mg²⁺ depletion from intestinal losses
Metabolic acidosis: Bicarbonate losses (jejunum: 30-40 mEq/L)
Malnutrition: Protein loss (50-100 g/day) plus malabsorption

Management Principles: "SNAP-IT-OFF"

S - Sepsis control: Drain collections, antibiotics, source control N - Nutrition: Early parenteral nutrition; goal 25-30 kcal/kg/day, protein 1.5-2.0 g/kg/day A - Anatomy definition: CT fistulography defines fistula tract P - Protection of skin: Barrier creams, ostomy appliances, negative pressure wound therapy I - Inhibit output (see below) T - Tincture of time: Spontaneous closure takes 4-6 weeks; surgery contraindicated <6 months unless life-threatening O - Optimize nutrition: Reassess nutritional parameters F - Fix it surgically: After 6-12 months if no closure F - Follow-up: Long-term nutritional assessment

Reducing Fistula Output: Medical Strategies

Pearl: The goal is to "dry up" the fistula, creating conditions favoring spontaneous closure.

1. Proton Pump Inhibitors:

Pantoprazole 40 mg IV BID reduces gastric secretions (1.5-2.5 L/day baseline)
Particularly effective for proximal fistulas

2. H₂ Receptor Antagonists:

Famotidine 20 mg IV BID as alternative or adjunct

3. Octreotide (Somatostatin Analog):

Dose: 100-250 mcg SC TID or 25-50 mcg/h IV continuous infusion
Reduces intestinal secretions by 30-50%
Decreases splanchnic blood flow, inhibits GI hormones
Most effective for pancreatic and proximal small bowel fistulas
Cost-benefit ratio debated; reserve for high-output fistulas (>1 L/day)[13]

Hack: Start octreotide at 50 mcg SC TID and titrate upward based on output response over 48 hours. Maximum doses (500 mcg TID) rarely provide additional benefit beyond 250 mcg TID.

4. Loperamide:

4 mg PO QID for ileostomy/ileal fistula output >1500 mL/day
Slows intestinal transit, enhances water absorption
Particularly effective when combined with dietary modifications

5. Cholestyramine:

4 g PO with meals for patients with <100 cm residual small bowel
Binds bile salts, reducing secretory diarrhea
Contraindicated if complete biliary obstruction suspected

Fluid and Electrolyte Replacement Protocol

Oyster: Normal saline replacement alone causes hyperchloremic metabolic acidosis. Fistula output contains bicarbonate that must be replaced.

Practical replacement formula:

Maintenance fluids: 1.5-2.0 L/day
PLUS mL-for-mL fistula output replacement using:
- 50% Normal Saline
- 50% Ringer's Lactate
Add KCl 20-40 mEq/L (adjust based on serum levels)

Supplemental electrolyte replacement:

Magnesium: 2-4 g IV daily (or continuous infusion 1-2 g/24h)
Zinc: 15-20 mg IV daily (promotes wound healing)
Calcium: Monitor ionized Ca²⁺; replacement as needed

Hack: Create a standardized "fistula replacement solution" in your ICU pharmacy:

1000 mL solution containing:
- 500 mL NS + 500 mL LR
- KCl 30 mEq
- MgSO₄ 2 g
Zinc sulfate 15 mg
Infuse mL-for-mL with 8-hour fistula output

Pearl: Measure fistula output every 8 hours, not every 24 hours. This allows timelier fluid replacement and prevents hypovolemia overnight when nurses are less likely to notice accumulating losses.

The Role of Post-Pyloric Feeding in the Unstable Patient with Gastric Ileus

Rationale for Post-Pyloric Nutrition

Critically ill patients demonstrate impaired gastric emptying from multiple factors: opioid analgesics, catecholamine infusions, sepsis, and hyperglycemia. Gastric ileus increases aspiration risk and delays nutritional support. However, small bowel motility recovers earlier than gastric motility post-operatively (24-48h vs. 48-72h), creating a window for successful post-pyloric feeding[14].

Evidence Base

Meta-analyses demonstrate that post-pyloric feeding reduces pneumonia risk (OR 0.7, 95% CI 0.55-0.89) compared with gastric feeding in high-risk ICU patients[15]. However, survival benefits remain unproven. Post-pyloric access should be targeted to specific populations:

Indications:

Recurrent aspiration on gastric feeding
High gastric residual volumes (>500 mL) despite prokinetics
Severe gastroparesis
Post-operative gastric/pancreatic/esophageal surgery
Patients requiring prone positioning

Placement Techniques

1. Bedside Blind Placement:

Success rate: 60-80% in experienced hands
Use weighted feeding tubes (e.g., Corpak self-advancing tubes)
Position patient in right lateral decubitus for 4-6 hours post-insertion
Metoclopramide 10 mg IV 30 minutes before insertion improves success

Hack: Inject 10 mL air through feeding tube while advancing. The characteristic "rumbling" sound heard on abdominal auscultation in the left upper quadrant indicates gastric coiling; withdrawal 5-10 cm often allows passage through the pylorus.

2. Electromagnetic Guidance (Cortrak):

Real-time guidance system
Success rate: 85-95%
Reduces fluoroscopy/endoscopy need
Cost-effective in centers with high volume

3. Endoscopic Placement:

Gold standard for difficult cases
Success rate: >95%
Allows direct visualization
Can be combined with PEG-J (percutaneous endoscopic gastrostomy-jejunostomy) for long-term access

4. Fluoroscopic Placement:

Traditional alternative
Requires radiology transport (contraindicated in unstable patients)

Oyster: Always confirm post-pyloric position radiographically before initiating feeding. Auscultation and pH testing are unreliable for distinguishing gastric from duodenal positioning.

Feeding Protocol

Initiation:

Begin at 10-20 mL/h (trophic feeding) within 24-48 hours of ICU admission
Advance by 10-20 mL/h every 4-6 hours as tolerated
Target goal rate by 48-72 hours

Formula selection:

Standard polymeric formulas appropriate for most patients
Semi-elemental formulas (Peptamen, Vital) for severe malabsorption
Immune-enhancing formulas (arginine, glutamine, omega-3) show benefit in select populations (trauma, major surgery)

Pearl: Don't check gastric residual volumes when feeding post-pylorically. This outdated practice derives from gastric feeding protocols and is not physiologically relevant for jejunal feeding.

Monitoring:

Abdominal examination every 4-6 hours
Watch for feeding intolerance: distension, increased abdominal pain, diarrhea (>1000 mL/day)
If diarrhea develops, consider Clostridium difficile testing, reduce rate temporarily, try fiber-containing or semi-elemental formula

Hack: For patients with persistent diarrhea on jejunal feeding, add soluble fiber (e.g., banana flakes 15 g/day added to formula bag) before abandoning enteral nutrition. Fiber bulks stool and slows transit.

Transitioning: Once gastric function recovers (tolerating medications, reduced NG output), pull back feeding tube to stomach or switch to oral diet. Post-pyloric feeding is a temporary bridge, not a destination.

Damage Control Surgery and the Open Abdomen: Critical Care of the Planned Re-look

Principles of Damage Control Surgery

Damage control surgery (DCS) represents a paradigm shift: abbreviating initial operation to control hemorrhage and contamination while deferring definitive repair until physiologic recovery[16]. The DCS sequence includes:

Part I: Abbreviated laparotomy (hemorrhage control, contamination control, temporary closure)
Part II: ICU resuscitation (correct hypothermia, acidosis, coagulopathy—the "lethal triad")
Part III: Planned re-exploration (definitive repair, often 24-72h later)

Indications for DCS include severe trauma, ruptured abdominal aortic aneurysm, necrotizing pancreatitis, mesenteric ischemia, and severe intra-abdominal sepsis where prolonged surgery risks physiologic exhaustion.

Open Abdomen Management

Temporary abdominal closure (TAC) techniques have evolved dramatically:

Vacuum-Assisted Closure (VAC/Negative Pressure Wound Therapy):

Current gold standard
Typical technique: Perforated plastic visceral protective sheet → moist surgical towels → occlusive adhesive drape → suction (125 mmHg continuous)
Proprietary systems (ABThera, V.A.C. Abdominal Dressing) offer standardized approach
Benefits: Fascial tension reduction, fluid removal (500-2000 mL/day), prevention of adhesions, facilitated delayed closure

Pearl: Apply skin-protective barrier (e.g., Cavilon) to surrounding skin before applying adhesive drape. This prevents moisture-associated skin injury and allows repeated dressing changes without tissue trauma.

Critical Care Priorities

1. Hemodynamic Optimization:

Open abdomen patients require meticulous resuscitation balancing adequate perfusion against avoiding fluid overload that prevents fascial closure.

Target parameters:

MAP >65 mmHg
Lactate clearance >10%/h
UOP >0.5 mL/kg/h
ScvO₂ >70%

Oyster: Excessive crystalloid resuscitation (>10 L in first 24h) creates visceral edema ("frozen abdomen") that prevents closure. After initial resuscitation, switch to restrictive fluid strategy and early vasopressors.

2. Nutritional Support:

Open abdomen patients are hypermetabolic (130-150% predicted energy expenditure) with massive protein losses (40-80 g/day via wound and fistula formation).

Strategy:

Early enteral nutrition (post-pyloric if gastric ileus)
Protein goal: 2.0-2.5 g/kg/day
If enteral feeding inadequate after 3-5 days, supplement with parenteral nutrition
Target positive nitrogen balance

3. Prevention of Fistula Formation:

ECF develops in 5-25% of open abdomen patients, predominantly when bowel adheres to anterior abdominal wall[17].

Protective strategies:

Non-adherent plastic sheeting (perforated polyethylene, PTFE) between bowel and abdominal wall
Minimize bowel handling during dressing changes
Early fascial closure (ideally <7-10 days)
Consider biologic mesh interposition if primary fascial closure impossible

Hack: Use a "silo" technique for patients with significant visceral edema preventing fascial approximation. Create progressive closure by serially tightening retention sutures 2-3 cm every 24-48 hours. This gradual approach increases closure success rates from 60% to >80%.

4. Timing of Definitive Closure:

Ideal window: 3-7 days post-initial operation when:

Hemodynamic stability achieved
Coagulopathy resolved (INR <1.5, platelets >75,000)
No ongoing infection
Lactate normalized
Feasible fascial approximation without tension

Oyster: Don't wait too long. Fascial closure rates decrease dramatically after 7-10 days as myofibroblast infiltration and lateral retraction of fascia occur. By 14 days, primary closure becomes nearly impossible.

Temporary closure plan if primary fascial closure impossible:

Biologic mesh (acellular dermis) as bridge
Plan for delayed definitive reconstruction at 6-12 months (component separation, anterior component separation with TAR)
Alternatively, "planned ventral hernia" with skin grafting over granulated viscera

5. Infection Control:

Open abdomen patients have 30-40% risk of secondary intra-abdominal infection.

Prevention:

Targeted antimicrobial therapy (not empiric)
Remove devitalized tissue at each re-exploration
Control all fistulas
Remove VAC dressing every 48-72 hours to inspect for abscess formation
Low threshold for CT imaging if sepsis develops

Pearl: If planning multiple re-operations, consider retention sutures placed through all layers 5 cm lateral to fascial edge at initial operation. These can be serially tightened, preventing complete lateral retraction and facilitating eventual closure.

Conclusion

Managing the critically ill surgical gut requires mastery of pathophysiology, meticulous attention to metabolic derangements, and clinical judgment regarding timing of interventions. The gut indeed serves as the motor of MOF—its dysfunction propagates systemic inflammation while its successful management prevents progression to irreversible organ failure.

Key principles include early recognition and graded management of intra-abdominal hypertension before ACS develops; distinguishing post-operative ileus from Ogilvie's syndrome to avoid unnecessary surgery while preventing perforation; aggressive fluid/electrolyte replacement in high-output fistulas/stomas while reducing output pharmacologically; utilizing post-pyloric feeding to provide early nutrition in patients with gastric ileus; and optimizing the complex care of open abdomen patients to achieve successful fascial closure while preventing complications.

As intensivists, our role extends beyond hemodynamic support—we must serve as stewards of the gut, recognizing that its health determines our patients' ultimate recovery.

References

Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10(6):350-356.
Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190-1206.
Malbrain ML, Chiumello D, Pelosi P, et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med. 2005;33(2):315-322.
Cheatham ML, Malbrain ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med. 2007;33(6):951-962.
Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF. Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. J Trauma. 2000;49(4):621-626.
De Waele JJ, Hoste EA, Malbrain ML. Decompressive laparotomy for abdominal compartment syndrome—a critical analysis. Crit Care. 2006;10(2):R51.
Saunders MD. Acute colonic pseudo-obstruction. Best Pract Res Clin Gastroenterol. 2007;21(4):671-687.
Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie's syndrome): an analysis of 400 cases. Dis Colon Rectum. 1986;29(3):203-210.
Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341(3):137-141.
Geller A, Petersen BT, Gostout CJ. Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc. 1996;44(2):144-150.
Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am. 1996;76(5):1009-1018.
Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004;91(12):1646-1651.
Rahbour G, Siddiqui MR, Ullah MR, Yassin NA, Thomas GP. A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg. 2012;256(6):946-954.
Taylor SJ, Fettes SB, Jewkes C, Nelson RJ. Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury. Crit Care Med. 1999;27(11):2525-2531.
Jiyong J, Tiancha H, Huiqin W, Jingfen J. Effect of gastric versus post-pyloric feeding on the incidence of pneumonia in critically ill patients: observations from traditional and Bayesian random-effects meta-analysis. Clin Nutr. 2013;32(1):8-15.
Rotondo MF, Schwab CW, McGonigal MD, et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35(3):375-382.
Björck M, Bruhin A, Cheatham M, et al. Classification—important step to improve management of patients with an open abdomen. World J Surg. 2009;33(6):1154-1157.

Author Note: This review integrates evidence-based guidelines with practical clinical experience. Postgraduate critical care trainees should supplement this knowledge with hands-on supervised experience and institutional protocols. The management of the critically ill surgical gut remains as much art as science, requiring clinical judgment refined through experience.

learningmedicine

Friday, October 31, 2025

The Gut as the Motor of multiple organ failure